1P-MiPLA

Pharmaceutical compound From Wikipedia, the free encyclopedia

1P-MiPLA, also known as 1-propanoyl-lysergic acid methylisopropylamide (1-propanoyl-MiPLA), is a designer drug and presumed serotonergic psychedelic of the lysergamide family related to lysergic acid diethylamide (LSD).[1][2][3] It is the 1-propanoyl derivative of MiPLA and may act as a prodrug of MiPLA.[1][2][3] 1P-MiPLA has been discussed on specialized online forums since 2018.[1] In addition, a designer drug product labeled "1P-MiPLA" but actually containing MiPLA was encountered in Austria in 2019.[1]

Other names1P-MIPLA; 1-Propanoyl-lysergic acid methylisopropylamide; 1-Propanoyl-MiPLA; N,6-Dimethyl-1-propanoyl-N-(propan-2-yl)-9,10-didehydroergoline-8β-carboxamide
ATC code
  • None
Quick facts Clinical data, Other names ...
1P-MiPLA
Clinical data
Other names1P-MIPLA; 1-Propanoyl-lysergic acid methylisopropylamide; 1-Propanoyl-MiPLA; N,6-Dimethyl-1-propanoyl-N-(propan-2-yl)-9,10-didehydroergoline-8β-carboxamide
Drug classSerotonergic psychedelic; Hallucinogen
ATC code
  • None
Identifiers
  • (6aR,9R)-N,7-dimethyl-4-propanoyl-N-(propan-2-yl)-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
PubChem CID
ChemSpider
Chemical and physical data
FormulaC23H29N3O2
Molar mass379.504 g·mol−1
3D model (JSmol)
  • CCC(=O)n1cc2c3c1cccc3C1=C[C@H](CN([C@@H]1C2)C)C(=O)N(C(C)C)C
  • InChI=1S/C23H29N3O2/c1-6-21(27)26-13-15-11-20-18(17-8-7-9-19(26)22(15)17)10-16(12-24(20)4)23(28)25(5)14(2)3/h7-10,13-14,16,20H,6,11-12H2,1-5H3/t16-,20-/m1/s1
  • Key:ISWISZIALPXJJD-OXQOHEQNSA-N
Close

Use and effects

Interactions

Society and culture

Canada

1P-MiPLA is a controlled substance in Canada under phenethylamine blanket-ban language.[4]

United States

1P-MiPLA is not an explicitly controlled substance in the United States.[5] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.

See also

References

Related Articles

Wikiwand AI